COSCIENS Biopharma Inc. revenue for the last year amounted to 4.50 M USD, the most of which — 4.58 M USD — came from its highest performing source at the moment, Biopharmaceutical, the year earlier bringing 5.42 M USD. The greatest contribution to the revenue figure was made by Switzerland — last year it brought COSCIENS Biopharma Inc. 4.40 M USD, and the year before that — 5.18 M USD.